A rare strain of the Ebola virus has spread across the Democratic Republic of Congo and neighboring Uganda, infecting patients and healthcare workers.
This outbreak is particularly critical because the Bundibugyo strain lacks an approved vaccine, leaving medical teams and local populations vulnerable to a virus that appears to be outrunning detection efforts.
The outbreak emerged in early May, with public reports first appearing on May 18 [1]. As of May 20, officials confirmed 27 cases and 12 deaths [2]. Among those infected are healthcare workers and an American doctor [1, 2].
The virus has affected the Ituri, North Kivu, and South Kivu provinces in the eastern DRC, as well as regions in Uganda [3, 4]. To combat the spread, the DRC government announced the opening of three treatment centers in Ituri [1].
"We will open three treatment centers in Ituri to respond quickly and protect our communities," said DRC Health Minister Dr. Eteni Longondo [1].
Virologists note that this specific strain, first identified in 2007 [4], presents unique challenges. The virus appears to have a longer incubation period and higher transmissibility than previous outbreaks [2, 4].
"This strain appears to have a higher reproductive number than previous Ebola outbreaks, making it harder to contain," said virologist Dr. Jean-Jacques Muyembe [4].
Limited surveillance and frequent cross-border movement between the two nations allowed the virus to spread before health authorities could identify the source [2, 4].
"We are closely monitoring the situation and working with partners to contain the outbreak," said WHO Director-General Dr. Matshidiso Moeti [2].
“The Bundibugyo strain lacks an approved vaccine, leaving medical teams and local populations vulnerable.”
The emergence of the Bundibugyo strain highlights a significant gap in global pandemic preparedness. While vaccines exist for other Ebola variants, the lack of a licensed vaccine for this specific strain, combined with its higher reproductive rate, increases the risk of a prolonged cross-border crisis. The infection of healthcare workers, including an international physician, underscores the high danger of transmission in clinical settings where diagnostic delays can occur.
